Semaglutide Side Effects: What to Expect in the First Few Weeks 

TL;DR Semaglutide commonly causes mild to moderate digestive side effects such as nausea, diarrhoea, vomiting, and constipation, especially in the first few weeks or after dose increases. These effects usually improve as your body adjusts. Starting at a low dose and gradually increasing helps minimise symptoms. Simple steps like eating smaller meals, staying hydrated, and avoiding fatty foods can make side effects more manageable.

Starting semaglutide for weight loss or type 2 diabetes management is a significant step. Whether you have been prescribed Wegovy or Ozempic, or are considering these treatments, understanding what your body may experience in the first few weeks is one of the most practical things you can do before your first injection.

This guide explains exactly what to expect, when to expect it, why these effects occur, and how to manage them. It is based on published clinical trial data, prescribing information from the MHRA-approved formulations, and practical pharmacy guidance. 

What Are Semaglutide Side Effects and Why Do They Happen?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone naturally produced in the gut in response to food. Its primary functions include stimulating insulin release from the pancreas, suppressing glucagon (a hormone that raises blood sugar), slowing gastric emptying, and signalling satiety (fullness) to the brain.

Semaglutide mimics the action of natural GLP-1. It is available under two brand names in the UK: Ozempic (licensed for type 2 diabetes management) and Wegovy (licensed for weight management in adults with obesity or overweight with a related health condition). 

The side effects of semaglutide, particularly the gastrointestinal ones, occur directly because of how the drug works. Slowing gastric emptying is a fundamental part of semaglutide’s mechanism of action: it keeps food in the stomach longer, prolonging satiety and blunting post-meal blood glucose spikes. However, this same mechanism is responsible for nausea, bloating, vomiting, and early satiety, especially when the body has not yet adapted to the drug.

Figure 1: Frequency of Most Common Semaglutide Side Effects in Clinical Trials. Sources: STEP 1 Trial, Wegovy prescribing information, Novo Nordisk.

The Most Common GLP-1 Side Effects: Gastrointestinal Symptoms

Semaglutide Nausea First Few Weeks

Nausea is the single most frequently reported side effect of semaglutide. In the STEP 1 trial, approximately 44% of participants in the Wegovy group reported nausea at some point during treatment. 

Nausea from semaglutide typically begins within the first one to three days of starting the medication or increasing the dose. It is most intense in the first few weeks and tends to improve significantly as the body adapts. 

Does Semaglutide Cause Vomiting or Diarrhoea?

Vomiting occurs in approximately 24% of Wegovy users, though it is generally less common than nausea and tends to correlate with nausea severity. It is more likely at higher doses and during the first weeks of a new dose level.

Diarrhoea is reported in around 30% of users across the STEP trials. It tends to be transient, often resolving within a week of onset, and is more likely if you consume high-fat or high-sugar foods. In the Ozempic trials for type 2 diabetes, approximately one in twelve participants reported diarrhoea.

Constipation is also common, reported in around 24% of users across clinical trial populations. It may seem contradictory that both diarrhoea and constipation appear on the side effect list, but this reflects the variability in individual responses to slowed gastric emptying. 

Abdominal Pain and Bloating

Abdominal discomfort, including cramping, bloating, and a sensation of fullness or pressure, is reported in approximately one in fourteen patients in the Ozempic clinical trials. This is a direct consequence of slowed gastric emptying and increased gastrointestinal transit time. Like other GI side effects, it typically improves as the body adjusts to the medication. 

Figure 2: Semaglutide Side Effects Week by Week Timeline. Sources: STEP trials, Wegovy/Ozempic prescribing information.

Semaglutide First Week Side Effects: A Week-by-Week Breakdown

Weeks 1 to 4: The Starter Dose (0.25mg)

The approved Wegovy titration begins at 0.25mg weekly. This dose is specifically used to allow your body to acclimatise before the dose is increased. The 0.25mg dose does not produce meaningful weight loss or blood sugar reduction on its own.

Most people experience:

• Mild nausea in the first few days after their initial injection. This often settles within 24 to 48 hours. 
• A reduced appetite is commonly noticed within the first week, which is one of the earliest signs that the medication is beginning to work. 
• Some people also report a slight headache or mild fatigue in the first week.

However, those who eat large, high-fat meals in the first days after starting treatment, or who consume alcohol, are more likely to experience significant nausea in the first week.

Weeks 5 to 8: The First Dose Increase (0.5mg)

After four weeks at 0.25mg, the dose is increased to 0.5mg. This is typically when people notice a more significant increase in side effects.

• Nausea tends to intensify during the first one to two weeks of the new dose, then progressively improves.
• Vomiting becomes more common at this stage, particularly if large meals, rich foods, or alcohol are consumed. 
• Diarrhoea or constipation may develop or worsen. 

Most people find that by weeks seven and eight, their gastrointestinal symptoms at the 0.5mg level are considerably more manageable than they were in weeks five and six.

Weeks 9 to 16: Progressive Dose Escalation (1.0mg to 1.7mg)

By the time most patients reach the 1.0mg dose, they have generally developed a good understanding of their personal side effect triggers and have adopted dietary strategies that minimise discomfort. Appetite suppression is well-established at this stage, and meaningful weight loss is typically underway.

Week 17 and Beyond: Maintenance Dose (2.4mg for Wegovy)

By the time the full maintenance dose is reached, the majority of patients experience significantly reduced side effect burden compared to the early weeks. 

While gastrointestinal adverse events were more common in the semaglutide group than in the placebo group overall, these were mostly mild to moderate and occurred predominantly in the early titration phase rather than persisting throughout the two-year treatment period.

Rare but Serious Side Effects of Ozempic and Wegovy

Pancreatitis

Acute pancreatitis has been reported in patients using semaglutide. In clinical trials, the frequency was low and broadly comparable to placebo groups. However, severe upper abdominal pain that radiates to the back, especially if accompanied by nausea, vomiting, and fever.

Gallbladder Disease

Cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) have been reported more frequently in semaglutide-treated patients. This is linked to rapid weight loss, which is a risk factor for gallstone formation. Maintaining adequate dietary fat intake during treatment and not losing weight too rapidly may help reduce this risk.

Thyroid C-Cell Concerns

All semaglutide formulations carry a boxed warning regarding dose-dependent thyroid C-cell tumours observed in rodent studies. However, semaglutide is contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). If you notice any neck swelling, hoarseness, or difficulty swallowing while on semaglutide, contact your prescriber promptly. 

How Long Do Semaglutide Side Effects Last?

The following timeframes are supported by clinical trial data and prescribing information:

• Nausea: Most commonly peaks in the first one to two weeks at each dose level, then improves significantly over weeks three to four. 
• Vomiting: Tends to follow a similar pattern to nausea. Isolated vomiting is less common and usually self-limiting within days.
• Diarrhoea: Often resolves within approximately one week of onset. Dietary modification, particularly avoiding high-fat and high-sugar foods, significantly reduces duration.
• Constipation: May last six to ten weeks in some individuals. Increasing fibre intake, hydration, and daily physical activity helps.
• Fatigue: Most commonly resolves within the first four to eight weeks as caloric intake stabilises and the body adapts.

The key principle to understand is that semaglutide side effects are most pronounced at the moment of dose escalation and progressively diminish as the body adjusts.

Weight Loss Injection Side Effects: Practical Management Tips

Figure 3: Practical Tips to Manage Semaglutide Side Effects. Adapted from clinical prescribing guidance.

Dietary Adjustments That Reduce GI Side Effects

• Eat smaller, more frequent meals: Three large meals are far more likely to trigger nausea than five or six smaller ones. 
• Eat slowly and stop when you feel full: Semaglutide prolongs satiety signals. Eating past the point of fullness dramatically increases the risk of vomiting.
• Avoid high-fat, fried, or greasy foods: These slow gastric emptying further and are the most reliable dietary trigger for nausea and vomiting on semaglutide.
• Avoid spicy foods and carbonated drinks: Both can exacerbate nausea and bloating.
• Do not skip meals: Eating nothing at all on an empty stomach can intensify nausea. A small meal is generally better than fasting.
• Ensure adequate protein intake: Aim for 1.2 to 1.6g of protein per kilogram of body weight daily to preserve lean muscle mass during weight loss.

Hydration and Lifestyle

• Stay well hydrated: Dehydration worsens nausea and fatigue. Sip water consistently throughout the day rather than drinking large amounts at once.
• Avoid alcohol: Alcohol is a potent trigger for nausea on semaglutide and can cause disproportionate blood sugar fluctuations.
• Maintain light physical activity: Gentle walking helps gastric motility and reduces constipation without placing excessive demands on energy reserves.
• Maintain regular sleep: Poor sleep causes fatigue and makes nausea harder to manage.

Injection Technique and Timing

• Rotate injection sites: Use the abdomen, outer thigh, or upper arm, rotating the specific location within each area each week. 
• Inject at a consistent day and time: Semaglutide is a once-weekly injection. Keeping the day and time consistent maintains stable drug levels.
• Ensure correct storage: Keep the pen refrigerated at 2 to 8 degrees Celsius. Once in use, it can be stored at room temperature (below 30 degrees). Do not freeze.
• Consider injecting in the evening: Some people find that injecting before bed means the peak of any initial side effects occurs during sleep, reducing daytime disruption. 

Start Your Weight Loss Journey With Batley Pharmacy

Understanding semaglutide side effects before you start treatment, and knowing how to manage them if they arise, is the single most effective way to stay on track and achieve your health goals. The side effects are predominantly temporary, manageable with the right strategies, and do not outweigh the substantial benefits semaglutide offers for weight management and metabolic health.

At Batley Pharmacy, our team provides expert, personalised support for people on GLP-1 weight loss treatments. Whether you are considering semaglutide for the first time, are currently navigating the dose escalation phase, or have questions about managing specific side effects, we are here to help.

FAQs